Dr. Bischof’s primary research focus is
understanding the molecular, neuronal and functional underpinnings of Alzheimer’s Disease (AD). He utilizes various imaging modalities, such as Positron Emission Tomography (PET) or Magnet Resonance Imaging (MRI) to investigate the main culprits of neurodegeneration in AD and their behavioral consequences.
Additionally, his interest lies in understanding normal aging as there is much too be learned from differential aging processes as it may give rise to the differences that underlies successful and unsuccessful aging.
Hoenig MC, Bischof GN, Seemiller J, Hammes J, Kukolja J, Onur ÖA, Jessen F, Fliessbach K, Neumaier B, Fink GR, van Eimeren T, Drzezga A. Networks of tau distribution in Alzheimer’s disease. Brain. 2018 Feb 1;141(2):568-581.
Bischof GN, Endepols H, van Eimeren T, Drzezga A.Tau-imaging in neurodegeneration. Methods. 2017 Nov 1;130:114-123.
Bischof GN, Jessen F, Fliessbach K, Dronse J, Hammes J, Neumaier B, Onur O, Fink GR, Kukolja J, Drzezga A, van Eimeren T; Alzheimer’s Disease Neuroimaging Initiative. Impact of tau and amyloid burden on glucose metabolism in Alzheimer’s disease. Ann Clin Transl Neurol. 2016 Oct 20;3(12):934-939.
Bischof GN (2016). Alzheimer’s disease risk: amyloid versus neurodegeneration. Lancet Neurology. Sep;15(10):1000-1.